Short interest is important to track because it can act as an indicator of market sentiment towards a particular stock. An ...

Shares of Danaher Corp. slipped 4.47% to $187.82 Wednesday, on what proved to be an all-around mixed trading session for ...

The focus will initially be on creating computational and digital pathology products, as well as AI-assisted algorithms.

DHR and AstraZeneca team up to develop AI-powered diagnostics, aiming to boost precision medicine by improving patient ...

Danaher Corporation (NYSE:DHR) and AstraZeneca PLC (NASDAQ:AZN) have announced a major partnership to accelerate the ...

Danaher Corp. closed 32.84% short of its 52-week high of $281.70, which the company reached on August 1st.

The new SCIEX OS software version 4.0 is the latest evolution of its powerful software platform. This new Microsoft Windows 11 compatible release drives operability enhancements with speed and ...

Danaher and AstraZeneca have formed a partnership to develop diagnostic tools that help clinicians better determine which patients would benefit from precision medicine treatments.

Danaher has entered a partnership with AstraZeneca to scale precision medicine, including developing the next generation of AI-powered diagnostics This partnership aims to create a framework for rapid ...

Through its Danaher Business System, Danaher aims for continuous improvement of its scientific technology portfolio by seeking out attractive markets and then making acquisitions to enter or ...

Through its Danaher Business System, Danaher aims for continuous improvement of its scientific technology portfolio by seeking out attractive markets and then making acquisitions to enter or ...

Danaher has maintained a net earning margin above 15% since 2017. In 2024 Q3, the company had a 36.36% liabilities-to-assets ratio, the lowest level since 2017. Danaher's largest customers have ...